142 results
Page 4 of 8
8-K
EX-99.1
04bnt ng01ry3s
6 Nov 19
Adaptimmune Reports Third Quarter 2019 Financial Results and Business Update
7:35am
8-K
EX-99.1
pzo81 64po1
30 Sep 19
Clear Benefit for Patients with Synovial Sarcoma Demonstrated in Updated Data from Ongoing
8:59am
8-K
EX-10.1
xtzm0aw mfydy
27 Aug 19
Entry into a Material Definitive Agreement
8:39am
8-K
EX-99.1
1ska9br7
25 Jul 19
Other Events
8:07am
8-K
EX-99.1
vgkkf56vyilf9wvh
18 Jul 19
Adaptimmune Starts the SURPASS Clinical Trial with its first Next-Generation SPEAR T-cells Targeting MAGE-A4 to Enhance Antitumor Responses
8:11am
8-K
EX-99.1
xcd25p1hfw07g
15 May 19
Adaptimmune and Alpine Immune Sciences Announce Collaboration and License Agreement to Develop Next-Generation SPEAR T-Cell Products
8:11am
8-K
EX-99.1
ms93yvs
6 May 19
Adaptimmune TRANSFORMING T CELL THERAPY Clinical and Business Update
8:11am
8-K
EX-99.1
6lf9yugjc 3wifi2
6 May 19
Significant Clinical Progress as Adaptimmune Announces Responses with ADP-A2M4 in Synovial Sarcoma and Antitumor Activity in Other Solid Tumors
7:08am
8-K
eqkdiqw
2 Apr 19
Other Events
8:10am
8-K
EX-99.1
ypfkwtdjy47
2 Apr 19
Other Events
8:10am
8-K/A
EX-99.1
oq2 wvsbka2a70
27 Feb 19
CORRECTING and REPLACING — Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
5:16pm
8-K
EX-99.1
vx0hu9h 9kbzrv5
27 Feb 19
Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
7:43am